-
February 12, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that it has enrolled the first patient in the phase IV ...
-
February 12, 2013
Perrigo Company (PRGO) recently announced that it is set to acquire a UK-based privately held pharmaceutical ...
-
February 11, 2013
Lannett Company, Inc. (LCI) reported second quarter fiscal 2013 earnings of 10 cents per share, above the Zacks ...
-
February 08, 2013
Supernus Pharmaceuticals, Inc. (SUPN) recently provided information on its agreement with Patheon Inc. (PNHNF) for ...
-
February 05, 2013
Supernus Pharmaceuticals, Inc. (SUPN) recently announced the launch of its antiepileptic drug, Oxtellar XR, in the ...
-
February 04, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently terminated its collaboration with CureTech Ltd. for the ...
-
January 31, 2013
Actavis, Inc. (ACT), formerly known as Watson Pharmaceuticals, Inc., recently provided an update on its 2012 ...
-
January 24, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced disappointing top-line results from a study evaluating ...
-
January 07, 2013
Pernix Therapeutics Holdings, Inc. (PTX) recently announced that it has completed the acquisition of Cypress ...
-
August 22, 2012
Sanofi's (SNY) vaccines division, Sanofi Pasteur, recently announced the launch of Sklice (ivermectin) Lotion, 0.5% ...
-
May 09, 2012
• Johnson & Johnson (NYSE:JNJ) reported Q1 EPS of $1.35, ex-items, ahead of the Zacks Consensus Estimate of $1.25 ...
-
April 28, 2012
In Part Two of our interview with Jim Rohrbach of Investment Models, the longtime trader describes his strategy for ...
-
June 21, 2011
With yields dropping, Vanguard has had to find ways to cut its already low expenses to keep yields off the floor, ...
